Edition:
India

People: CSPC Pharmaceutical Group Ltd (1093.HK)

1093.HK on Hong Kong Stock

17.40HKD
18 Oct 2019
Change (% chg)

HK$0.50 (+2.96%)
Prev Close
HK$16.90
Open
HK$16.92
Day's High
HK$17.58
Day's Low
HK$16.84
Volume
33,956,018
Avg. Vol
37,147,098
52-wk High
HK$19.26
52-wk Low
HK$9.90

Wang, Bo 

Mr. Wang Bo is Independent Non-Executive Director of CSPC Pharmaceutical Group Limited. He is also a member of the Audit Committee and Remuneration Committee of the Company. Mr. Wang is currently the CEO of Beijing CHNMED Pharmaceutical Technology Development Co., Ltd and managing director of Beijing CHNMED Pharmaceutical Consulting Co., Ltd.. Mr. Wang graduated from Beijing Institute of Iron and Steel and has extensive experience in pharmaceutical policy research and consulting. Mr. Wang is currently the distinguished researcher of the Research Center of National Drug Policy & Ecosystem. Mr. Wang is also an independent director of Henan Taloph Pharmaceutical Stock Co., Ltd. (listed on Shanghai Stock Exchange) and Jiuzhitang Co., Ltd. (listed on Shenzhen Stock Exchange).

Basic Compensation

Total Annual Compensation, HKD 100,000
Restricted Stock Award, HKD --
Long-Term Incentive Plans, HKD --
All Other, HKD --
Fiscal Year Total, HKD 100,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Dongchen Cai

13,805,000

Cuilong Zhang

4,326,000

Kin Man Chak

5,269,000

Chunlei Li

4,783,000

Hua Lu

4,205,000

Weidong Pan

4,387,000
As Of  31 Dec 2018